Ocular damage in chloroquine therapy.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002648:Child; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects* / Q000266:history; D003119:Color Perception Tests; D003117:Color Vision Defects / Q000139:chemically induced; D003315:Cornea / Q000187:drug effects*; D004596:Electroretinography; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005654:Fundus Oculi; D006666:History of Medicine; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009887:Ophthalmoscopy; D012029:Refraction, Ocular; D012160:Retina / Q000187:drug effects*; D012607:Scotoma / Q000139:chemically induced; D012871:Skin Diseases / Q000188:drug therapy; D058609:Visual Field Tests
D006886:Hydroxychloroquine; D002738:Chloroquine